President ECNP: Prof. Gitte Moos Knudsen Prof. Knudsen explains to Oruen exclusively, how COVID-19 has impacted ECNP’s plans and how they are planning to go virtual with their conference which was originally scheduled to take place in Vienna this September. For further information, please visit the link below as mentioned in the video: https://www.ecnp.eu/Informationandnews/corona-watch
Men with rheumatoid arthritis who have depression or depressive symptoms were significantly more likely to die compared with RA patients who were not depressed, according to data from a longitudinal cohort study of 530 patients. The findings were presented at the annual meeting of the American College of Rheumatology. The deleterious effect of depression on […]
The recent findings of significantly increased risk for cancer incidence and mortality in people with sleep apnea echo previous in vitro and animal studies that found repeated episodes of hypoxia were associated with accelerated cancer progression.
VANCOUVER, B.C. – Disordered sleep in mid- to late life is associated with an increased risk for future cognitive impairment and may alter the dynamics of the Alzheimer’s disease–associated protein amyloid-beta, according to several studies.
Cancer patients deserve to receive aggressive treatment for comorbid depression. Dr. David Spiegel and his team of researchers at Stanford University found that patients with depression may exhibit faster rates of cancer progression. The team found that depression was as dangerous a risk factor for mortality in cancer as it is in cardiovascular disease.
Recent discoveries in epigenetics could soon make a clinical difference for children with attention-deficit/hyperactivity disorder, autism spectrum disorder, and other conditions, according to an expert.